Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
03/29/2007 | WO2007010085A2 New pharmaceutical compounds |
03/29/2007 | US20070073093 Light emitting device and compounds for use therein |
03/29/2007 | US20070072871 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
03/29/2007 | US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
03/29/2007 | CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
03/28/2007 | EP1767535A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
03/28/2007 | EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
03/28/2007 | EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
03/28/2007 | CN1938288A 2-aminothiazole compounds useful as aspartyl protease inhibitors |
03/28/2007 | CN1938279A Modulators of atp-binding cassette transporters |
03/28/2007 | CN1935796A Method for preparing nitazoxanide |
03/28/2007 | CN1935795A 2-tert.-butoxyacylamino-3-[4'-2''-methylthiazol-4''-methoxy)-phenyl]-propionic acid and its industralized preparing method and use |
03/28/2007 | CN1307166C Oxazole/thiazol-derivatives activators of the HPPAR-alpha receptor |
03/28/2007 | CN1307165C 4-methyl-5-formylthiazole preparation method |
03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
03/27/2007 | US7196200 5-oxo-5,8-dihydro[2,3-d]pyrimidinopyridine-6-carboxylic acids or 7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acids; fish or mammals; bacterial protein biosynthesis inhibitors |
03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
03/27/2007 | US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases |
03/27/2007 | US7196107 Thia-and oxazoles and their use as ppars activators |
03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
03/27/2007 | US7195885 Hepatitis C virus assays |
03/27/2007 | CA2193460C 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation |
03/22/2007 | WO2007032028A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
03/22/2007 | WO2007031513A1 Pesticide thiazolyloxy substituted phenylamidine derivatives |
03/22/2007 | WO2007005785B1 Thiazoles derivatives as ampk activator |
03/22/2007 | WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors |
03/22/2007 | US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis |
03/22/2007 | US20070066586 Aniline derivatives |
03/22/2007 | US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
03/22/2007 | US20070066577 Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same |
03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
03/22/2007 | CA2622518A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
03/22/2007 | CA2619059A1 Pesticide thiazolyloxy substituted phenylamidine derivatives |
03/22/2007 | CA2617394A1 2-aniline-4-aryl substituted thiazole derivatives |
03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
03/21/2007 | EP1764110A1 Compositions comprising an insulin sensitivity enhancer and a biguanide |
03/21/2007 | EP1763502A1 Novel hexafluoroisopropanol derivatives |
03/21/2007 | EP1474406B1 Disubstituted thiazolyl carboxanilides and their use as microbicides |
03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
03/21/2007 | EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use |
03/21/2007 | CN1934077A 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
03/21/2007 | CN1933833A Aqueous composition comprising thiazole derivative |
03/21/2007 | CN1305862C 7-amino-benzothiazole derivatives as adenosine receptor ligands |
03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
03/20/2007 | US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents |
03/20/2007 | CA2220094C Process for producing guanidine derivatives, intermediates therefor and their production |
03/15/2007 | WO2007030618A2 Bicyclic derivatives as modulators of voltage gated ion channels |
03/15/2007 | WO2007029793A1 Aryl heterocyclic derivative and bactericide for agricultural and horticultural use |
03/15/2007 | WO2007029037A2 Class iia histone deacetylase (hdac) substrate |
03/15/2007 | WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
03/15/2007 | WO2007029035A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
03/15/2007 | WO2007028999A1 Thiazole compounds and their use as pgd2 antagonists |
03/15/2007 | US20070060618 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
03/15/2007 | US20070060587 Indane derivates as muscarinic receptor agonists |
03/15/2007 | US20070060584 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
03/15/2007 | US20070060480 Heteroaroyl-substituted phenylalanineamides |
03/15/2007 | CA2622076A1 Bicyclic derivatives as modulators of voltage gated ion channels |
03/15/2007 | CA2621448A1 Class iia histone deacetylase (hdac) substrate |
03/15/2007 | CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
03/15/2007 | CA2621443A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
03/15/2007 | CA2621406A1 Pparactive compounds |
03/14/2007 | EP1761511A1 Improved process for the preparation of biologically active tetrahydrobenzthiazole derivative |
03/14/2007 | EP1761486A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
03/14/2007 | EP1040103B1 Anilide derivative, production and use thereof |
03/14/2007 | CN1930155A Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
03/14/2007 | CN1930121A Substituted heteroaryl- and phenylsulfamoyl compounds |
03/14/2007 | CN1927848A Substituted acid compounds, preparation method and medicament use thereof |
03/14/2007 | CN1927843A Compound of 2-substituted alkylacrylate and application thereof |
03/14/2007 | CN1304394C Diastereomeric selective preparation method of lamivudine |
03/14/2007 | CN1304383C Benzothiazole derivatives |
03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
03/13/2007 | US7189857 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
03/13/2007 | US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
03/13/2007 | US7189750 Bis-[4-methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-amine for example; use to treat nitric oxide (NO)-mediated diseases such as cardiovascular diseases, inflammation, tumor suppression and psychiatric and neurological diseases; natural metabolite formed when NO is released, side effect reduction |
03/13/2007 | US7189749 Substituted phenoxyacetic acids |
03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
03/13/2007 | US7189722 Aryl spirohydantoin CGRP receptor antagonists |
03/13/2007 | US7189720 Selective NPY (Y5) antagonists |
03/08/2007 | WO2007027134A1 7-(2-AMINO-1-HYDROXY-ETHYL)-4-HYDROXYBENZOTHIAZOL-2(3H)-ONE-DERIVATIVES AS β2 ADRENOCEPTOR AGONISTS |
03/08/2007 | WO2007027133A1 7-(2-AMINO-1-HYDROXY-ETHYL)-4-HYDROXYBENZOTHIAZOL-2(3H)-ONE-DERIVATIVES AS β2 ADRENOCEPTOR AGONISTS |
03/08/2007 | WO2007026962A1 Phenylene derivative |
03/08/2007 | WO2007026761A1 Thiazole derivative |
03/08/2007 | WO2007026753A1 Method for producing 2-oxazoline analogue or 1,3-oxazine analogue |
03/08/2007 | WO2005112933A3 Substituted organosulfur compounds and methods of using thereof |
03/08/2007 | US20070055063 Preparation of thiazoles |
03/08/2007 | US20070054909 VLA-4 inhibitor compounds |
03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
03/08/2007 | US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy |
03/08/2007 | US20070054897 1,1-Dicyclohexyl-3-thiazol-2-yl-urea, 3-(5-Chloro-thiazol-2-yl)-1,1-dicyclohexyl-urea, for example; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
03/08/2007 | US20070054220 Polymeric material containing a latent acid, i.e. a compound which is not an acid but which can be converted to an acid by the influence of laser irradiation |
03/08/2007 | CA2621227A1 Thiazole derivative |
03/08/2007 | CA2620466A1 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as .beta.2 adrenoceptor agonists |
03/07/2007 | EP1759698A1 Novel method of treatment |
03/07/2007 | EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase |
03/07/2007 | EP1758874A1 Substituted thiazoleacetic acids as crth2 ligands |
03/07/2007 | EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics |